News RSS

BioClinica Announces Availability of Express EDCplus

Mon, 22 Apr 2013 00:00:00 GMT

BioClinica Announces Availability of Express EDCplus

– Robust yet Easy-to-Use Program Increases Sponsor Control Over Clinical Trial Timelines –

BioClinica®, Inc., a global provider of clinical trial management services, today announced the immediate availability of BioClinica Express EDCplus. Through the web-based EDCplus program, sponsors and CROs personnel can now directly build their own Express EDC (electronic data capture) studies. The program offers full access to the same system that BioClinica created to build thousands of studies over 15 years, without compromising on power or performance.

BioClinica Releases Integrated Medical Image Management Solution

Tue, 16 Apr 2013 00:00:00 GMT

BioClinica WebSend Improves Imaging Data Quality and Availability for Clinical Trials –

BioClinica®, Inc., a global provider of clinical trial management services, announced today the newest release of WebSend, the company's industry-leading medical image submission technology for clinical trials.

BioClinica WebSend is an electronic data transfer solution that offers significant value over other methods to collect and manage medical images for clinical trials. Investigator sites use WebSend to securely transmit medical images for clinical trials over the internet. Pharmaceutical clinical trial sponsors prefer WebSend to outdated alternatives and courier services because it improves the quality of their trial data, makes clinical imaging data immediately available for review, and reduces costs of conducting an imaging-based clinical trial.

BioClinica, Inc. to Demonstrate Technology-Enhanced Capabilities at Upcoming Global Industry Events

Tue, 02 Apr 2013 00:00:00 GMT

BioClinica®, Inc. a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in, and speak at several upcoming industry conferences in April, May, and June. BioClinica experts will discuss industry trends and demonstrate the company's suite of technologies and solutions. The conferences include:

BIOCLINICA AND CORELAB PARTNERS ARE ONE

Thu, 14 Mar 2013 00:00:00 GMT

BIOCLINICA AND CORELAB PARTNERS ARE ONE

- Combined Company Creates Clear Leader for Imaging Core Lab Services -

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, announced today that JLL Partners and Ampersand Capital Partners, two leading middle market private equity firms, have completed their acquisition of BioClinica and CoreLab Partners and have combined the two companies under the name BioClinica.

JLL PARTNERS TO ACQUIRE BIOCLINICA, INC., AND CORELAB PARTNERS

Wed, 30 Jan 2013 00:00:00 GMT

JLL PARTNERS TO ACQUIRE BIOCLINICA, INC., AND CORELAB PARTNERS

Transaction to create an industry leading provider of medical imaging and eClinical solutions for clinical trials

BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, today announced that it has entered into a definitive agreement to be acquired by a holding company controlled by JLL Partners, Inc., a leading private equity firm.

Simultaneously, JLL Partners announced that it has reached a definitive agreement to acquire CoreLab Partners, Inc., a provider of medical imaging solutions and cardiac safety services based in Princeton, N.J.

Following the proposed acquisitions, BioClinica and CoreLab Partners will be merged to create a leading provider of medical imaging services and best-in-class eClinical solutions for clinical trials. Ampersand Capital Partners, which is the majority owner of CoreLab Partners, will also be a significant investor in the combined company.

CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimer's Imaging Market Space

Thu, 06 Dec 2012 00:00:00 GMT

CoreLab Partners enters the early Alzheimer’s imaging market space

Princeton, NJ. December 6, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and medical imaging assessment, has launched new imaging capabilities targeted at the utilization of independent central image review in the detection of early Alzheimer’s disease.

CoreLab Partners collaborates at industry conferences worldwide

Tue, 15 May 2012 00:00:00 GMT

Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and medical imaging assessment, is set to attend and actively participate in several upcoming industry events around the world over the next several months.

CoreLab Partners Sees Opportunity in Japanese Healthcare Industry (as seen in media)

Wed, 21 Mar 2012 00:00:00 GMT

March 2012 -- CoreLab Partners, Inc. recently announced the opening of their new Japan office this January as the first step in their plans to grow their business in Asia. The result of a merger between medical imaging science and cardiac safety supply leaders Medifacts International and RadPharm, Inc. in February 2010, CoreLab Partners provides solutions for the collection, analysis and management of patient images and cardiac safety and efficacy information for clinical trials. With offices in North America, Europe and Asia, CoreLab Partners is a global leader in the medical imaging and cardiovascular corelab market sector.

CoreLab Partners opens office in Tokyo, Japan

Tue, 17 Jan 2012 00:00:00 GMT

Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and building a global presence as one of the largest imaging and cardiac safety core labs in the world,CoreLab Partners, Inc., today has announced the opening of an office in Tokyo, Japan under the wholly owned subsidiary of CoreLab Partners Japan, K.K.

CoreLab Partners now offers semi-automated ECG solutions

Mon, 24 Oct 2011 00:00:00 GMT

Princeton, NJ October 24, 2011 – CoreLab Partners, Inc. has launched a new semi automated ECG solution through its ongoing collaboration with Analyzing Medical Parameters for Solutions (A.M.P.S.) LLC.
“We are pleased to announce the release of our new semi-automated CalECG v3 solution for the analysis of ECGs” said CoreLab Partners’ President and Chief Executive Officer, Dr. Mike Woehler. “This new application represents our commitment to advancing technologies in the cardiac safety market sector and complements our established processes in our proprietary WebHeart® technology platform” added Woehler.

CoreLab Partners showcases technologies at 47th Annual DIA Meeting

Fri, 17 Jun 2011 00:00:00 GMT

Princeton, NJ June 17, 2011 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, will showcase several new technological solutions to coincide with the upcoming DIA meeting in Chicago, Illinois to be held from June 20 - 23, 2011.

CoreLab Partners collaborates at worldwide industry conferences

Fri, 25 Mar 2011 00:00:00 GMT

Princeton, NJ March 25, 2011 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, is set to attend and actively participate in several upcoming industry events around the world over the next two weeks.

CoreLab Partners launches advanced imaging application

Mon, 10 Jan 2011 00:00:00 GMT

Princeton, NJ January 10, 2011 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine.^®

CoreLab Partners launches new DXA imaging service offerings

Fri, 15 Oct 2010 00:00:00 GMT

Princeton, NJ October 15, 2010 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm Inc. and Medifacts International in February of this year, has launched a full suite of imaging service solutions and quality assurance processes as it relates to Dual Energy X-Ray Absorptiometry (DXA).

CoreLab Partners completes first TQT study in Japan

Wed, 06 Oct 2010 00:00:00 GMT

Princeton, NJ USA October 6, 2010 – CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm and Medifacts International in February of this year, has recently completed the first ever regulatory mandated Thorough QT (TQT) study conducted in the Asia Pacific Rim and the first TQT study for a Japanese new drug application (NDA).

CoreLab Partners launches new brand identity

Mon, 12 Apr 2010 00:00:00 GMT

CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.

RadPharm and Medifacts International Merge to Form Leading Independent Core Lab

Thu, 11 Feb 2010 00:00:00 GMT

RadPharm, Inc. a leading Imaging Core Laboratory and Medifacts International, Inc, a leading Cardiovascular Core Laboratory today announced the merger of their business operations. The combined company will be named CoreLab Partners (“CoreLabs”) and will have its corporate headquarters in Princeton, New Jersey.

RadPharm, Medifacts to Become CoreLab Partners - CWWeekly

Sun, 07 Feb 2010 00:00:00 GMT

Core laboratories Rad-Pharm and Medifacts International recently merged business operations, hoping to attract new clients with their combined portfolios.

See a pdf of the original publication here.

RadPharm, Inc ranked 3rd among New Jersey’s Fastest Growing 50 Companies

Mon, 23 Nov 2009 00:00:00 GMT

RadPharm Inc, a global provider of centralized medical image management services to the Biopharmaceutical and medical device industries, was recognized as the third-ranked company among the fifty nominated as one of "New Jersey’s Finest” in 2009.

Medifacts Reaches Milestone: 10,000 Sites Under Management Worldwide

Wed, 28 Oct 2009 00:00:00 GMT

MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiovascular diagnostic services, today announced that they have achieved a company milestone with 10,000 clinical trial sites spread across five continents currently under management.

RadPharm Supports Komen Race for the Cure

Thu, 22 Oct 2009 00:00:00 GMT

RadPharm Inc., a global imaging core lab with extensive experience in Oncology drug development, is pleased to pledge its continued support for the Susan G. Komen Race for The Cure.

RadPharm, Inc to Lead Sessions at the 4th Phacilitate Oncology Leaders Forum 2009

Mon, 12 Oct 2009 00:00:00 GMT

RadPharm Inc, a global provider of centralized medical image management services to the bio-pharmaceutical and medical device industries announced today that two key executives will be presenting during the upcoming 4th Phacilitate Oncology Leaders Forum 2009 to be held November 9-11, 2009, in Boston, MA. The conference, to be co-located with the Phacilitate 14th R&D Leaders Forum 2009, brings together senior level R&D and business development executives driving the development and launch of novel cancer therapeutics of all classes.

Medifacts Complete Spacelabs Integration

Thu, 08 Oct 2009 00:00:00 GMT

MEDIFACTS INTERNATIONAL, INC., a leading global cardiovascular core lab, announced today that they have completed the integration of SpaceLabs (CTS), forming the largest supplier of Ambulatory Blood Pressure Monitoring (ABPM) in the world. The completed integration of Medifacts International and CTS brings to the clinical trials market a combined company rich with technological and clinical process expertise, something that has been a hallmark of each.

Medifacts International & Suzuken Announce Successful Completion of a Japanese Study Utilizing WebHeart

Tue, 04 Aug 2009 00:00:00 GMT

MEDIFACTS INTERNATIONAL, INC. a leading global cardiovascular core lab today announced the successful completion of a Japanese study utilizing Medifacts industry-leading cardiac safety platform WebHeart®.

RadPharm to present at the upcoming ASCO 2009 Annual Meeting

Mon, 01 Jun 2009 00:00:00 GMT

RadPharm Inc., is pleased to announce the publication of an abstract and the release of two abstracts to be presented during oral presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held in Orlando, FL from May 30-June 1, 2009.

RadPharm Chief Medical Officer Co-authors Multiple Articles on New RECIST 1.1 Criteria Special Issue of European Journal of Cancer (EJC)

Mon, 23 Feb 2009 00:00:00 GMT

RadPharm Inc, a leading global provider of centralized medical imaging review services to biotechnology, pharmaceutical and medical device organizations is pleased to announce that their Founder and Chief Medical Officer, Robert Ford, M.D, is a contributing author to five articles which were included in the special RECIST 1.1 issue of the European Journal of Cancer.

RadPharm Appoints Steven F. Owens Chief Information Officer

Thu, 21 Aug 2008 00:00:00 GMT

RadPharm Inc, a leading Imaging CRO, has announced the appointment of Steven F. Owens to the position of Chief Information Officer. In this newly created role, Mr. Owens will serve on the executive committee and provide leadership to IT and development projects that enhance technical capabilities and strengthen business processes critical to delivering outstanding service to RadPharm clients.

Medifacts to Form Strategic Alliance in Japan with Suzuken

Mon, 21 Jul 2008 00:00:00 GMT

MEDIFACTS INTERNATIONAL, INC. a leading global cardiovascular core lab andSUZUKEN CO. Ltd – one of Japan’s largest cardiac safety services providers announce the formationof a strategic alliance to address the increasing need for cardiac safety testing on new drugs in Japan.

RadPharm Inc CEO Ronald A. Berg Named Ernst & Young Entrepreneur Of The Year® 2008 Award Finalist in New Jersey

Wed, 11 Jun 2008 00:00:00 GMT

RadPharm Inc., a leading imaging CRO, today announced that CEO, Ronald A. Berg, is a finalist for The New Jersey Ernst & Young Entrepreneur Of The Year® 2008 Awards. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mr. Berg was selected as a finalist from over 50 nominations by a panel of independent judges. Award winners will be announced at a special gala event on Thursday June 19th, 2008 at the Marriott Teaneck at Glenpointe, Teaneck, New Jersey.

Medifacts Initiates QT Study in 5 Days

Fri, 16 May 2008 00:00:00 GMT

INTERNATIONAL, INC. a leading provider of noninvasive cardiac safety services, announces the initiation of an important QT study in 5days.

Medifacts Rescues ECG Study in 7 Days

Thu, 15 May 2008 00:00:00 GMT

MEDIFACTS INTERNATIONAL, INC. a leading provider of noninvasive cardiac safety services, announces the rescue of a significant ECG study in record timelines. The study - a pivotal safety program already under way - required the rapid intervention of a new cardiac safety core lab in order to provide data integrity and

continuity for patients already enrolled.

Medifacts Initiates Over 2000 Sites in Fourth Quarter

Tue, 11 Dec 2007 00:00:00 GMT

MEDIFACTS INTERNATIONAL, INC. announces the initiation of over 2000 clinical sites in the fourthquarter of 2007. Facilitated by dedicated project teams and the scalability of the WebHeart® system, sites in 65countries received comprehensive, hands-on training at international Investigator Meetings, study-specificequipment and supplies, as well as follow up training, test transmissions and procedure confirmation.

RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital

Wed, 28 Nov 2007 00:00:00 GMT

RadPharm, Inc., a leading provider of medical image review services for clinical research, announced the completion of a $10 million Series B financing led by Siemens Venture Capital (“SVC”). Existing investors Ampersand Ventures, Adams Street Partners and Tang Capital Management participated in the financing.

News RSS

BioClinica Announces Availability of Express EDCplus

BioClinica Announces Availability of Express EDCplus – Robust yet Easy-to-Use Program Increases Sponsor Control Over Clinical Trial Timelines –

– Robust yet Easy-to-Use Program Increases Sponsor Control Over Clinical Trial Timelines –

BioClinica Releases Integrated Medical Image Management Solution

BioClinica, Inc. to Demonstrate Technology-Enhanced Capabilities at Upcoming Global Industry Events

BIOCLINICA AND CORELAB PARTNERS ARE ONE

JLL PARTNERS TO ACQUIRE BIOCLINICA, INC., AND CORELAB PARTNERS

CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimer's Imaging Market Space

CoreLab Partners collaborates at industry conferences worldwide

CoreLab Partners Sees Opportunity in Japanese Healthcare Industry (as seen in media)

CoreLab Partners opens office in Tokyo, Japan

CoreLab Partners now offers semi-automated ECG solutions

CoreLab Partners showcases technologies at 47th Annual DIA Meeting

CoreLab Partners collaborates at worldwide industry conferences

CoreLab Partners launches advanced imaging application

CoreLab Partners launches new DXA imaging service offerings

CoreLab Partners completes first TQT study in Japan

CoreLab Partners launches new brand identity

RadPharm and Medifacts International Merge to Form Leading Independent Core Lab

RadPharm, Medifacts to Become CoreLab Partners - CWWeekly

RadPharm, Inc ranked 3rd among New Jersey’s Fastest Growing 50 Companies

Medifacts Reaches Milestone: 10,000 Sites Under Management Worldwide

RadPharm Supports Komen Race for the Cure

RadPharm, Inc to Lead Sessions at the 4th Phacilitate Oncology Leaders Forum 2009

Medifacts Complete Spacelabs Integration

Medifacts International & Suzuken Announce Successful Completion of a Japanese Study Utilizing WebHeart

RadPharm to present at the upcoming ASCO 2009 Annual Meeting

RadPharm Chief Medical Officer Co-authors Multiple Articles on New RECIST 1.1 Criteria Special Issue of European Journal of Cancer (EJC)

RadPharm Appoints Steven F. Owens Chief Information Officer

Medifacts to Form Strategic Alliance in Japan with Suzuken

RadPharm Inc CEO Ronald A. Berg Named Ernst & Young Entrepreneur Of The Year® 2008 Award Finalist in New Jersey

Medifacts Initiates QT Study in 5 Days

Medifacts Rescues ECG Study in 7 Days

Medifacts Initiates Over 2000 Sites in Fourth Quarter

RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital

BioClinica Announces Availability of Express EDCplus

– Robust yet Easy-to-Use Program Increases Sponsor Control Over Clinical Trial Timelines –